Cowen And Company, LLC Acadia Pharmaceuticals Inc Put Options Transaction History

Cowen And Company, LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Aug 05, 2022	SELL	$13.01 - $27.22 $117,090 - $244,980	-9,000 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$20.94 - $27.5 $188,460 - $247,500	9,000 New	9,000 $11,000
Q2 2021 Aug 13, 2021	SELL	$19.4 - $27.42 $145,500 - $205,650	-7,500 Closed	0 $0
Q1 2021 May 04, 2021	BUY	$25.02 - $54.99 $187,650 - $412,425	7,500 New	7,500 $148,000
Q4 2020 Feb 08, 2021	SELL	$41.04 - $56.79 $853,632 - $1.18 Million	-20,800 Closed	0 $0
Q3 2020 Nov 03, 2020	BUY	$36.42 - $57.0 $757,536 - $1.19 Million	20,800 New	20,800 $51,000

279

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.76B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Cowen And Company, LLC with notifications on news.